1 / 12

What can Actavis contribute for the sustainability in the health care system?

What can Actavis contribute for the sustainability in the health care system?. GAP of unmeet needs. 100%. 0. Untreated patients or patients treated with “old” treatment. 90%. 10. 80%. 20. 70%. 30. 60%. 40. 50%. 50. 40%. 60. Number of patient treated by modern treatment

brynne-holder
Download Presentation

What can Actavis contribute for the sustainability in the health care system?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. What can Actavis contribute for the sustainability in the health care system?

  2. GAP of unmeet needs 100% 0 Untreated patients or patients treated with “old” treatment 90% 10 80% 20 70% 30 60% 40 50% 50 40% 60 Number of patient treated by modern treatment according treatment guidelines 30% 70 20% 80 10% 90 0% 100 WEST EuUROPE EAST

  3. CVD diseases mortality across Europe • Europe: 48 % of all death (4.3 Million) • EU-Europe (27 Member States): 42% (2 Mil) • CHD – Europe: one of five • 20% male - 22% female • Stroke – Europe: one of six to one of ten • 11% male – 17 % female

  4. Unequal distribution! Source: WHO 2004

  5. CVD and DALY loss

  6. Penetration of “Statins” Treatment Europe Treated patients 1 325 000 Treated patients 200 500

  7. Development of C10 Treatment in Czech Republic ROSUVA launch ATORVA for GP SIMVA for GP Source: IMS

  8. Czech Market C10 Number of Treated vs. Price per Treatment IMS MAT 6/2011 Retail

  9. Czech learning's • Release of treatment of statins to GPs • Rapid increase in number of patients treated by statins (10% of Czech population) • 10 fold increase in number of treated patients • 2 fold increase in yearly cost • Shift of “standards’ “Extension of modern treatment to primary care”

  10. Translation of Czech reality to Serbia • 10% of Czech population treated • In Serbia: ≈700 000 patient to be considered • Currently ≈ 200 000 patients treated GAP 500 000 patients

  11. Actavis role in bringing sustainability to healthcare system • Meeting healthcare needs • More affordable prices • Modern therapies • More patients treated • Overall cost saving …in partnership with relevant authorities and through transparent dialogue!

  12. Thank you!

More Related